Economy & PolicyAmid Air of Uncertainty with Tariffs, Indian Pharma Firms May Look at More Third-party ManufacturingBY Outlook Business Desk
NewsHealth Regulations Trigger Concerns Of Drug Shortages And Price Spikes In India, Says ReportBY Outlook Business Desk
NewsLeading 25 Domestic Pharma Cos Expected To See 9-11% Revenue Growth In FY24: IcraBY Press Trust of India
NewsIndia’s Drug Regulator To Collate Data Of Pharma Plants After Crackdown On Spurious MedicinesBY Outlook Business Desk
